Literature DB >> 326497

Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract.

R Duperval, P E Hermans, N S Brewer, G D Roberts.   

Abstract

Cryptococcus neoformans was isolated from 65 patients: 11 had meningitis, 11 had disseminated cryptococcosis without meningitis, and 43 had C neoformans isolated from the respiratory tract. Predisposing conditions and the diagnostic value of cultures from various sites and of the latex agglutination test on cerebrospinal fluid and serum are analyzed for patients with extrapulmonary disease. Nine patients had pleural effusions; the effusion was cultured in six and yielded C neoformans in four. None of 11 deaths among 43 patients with respiratory tract isolates could be attributed to cryptococosis. The 32 survivors were nor treated with antifungal agents. Twenty-six of 43 patients with respiratory isolates had various bronchopulmonary disorders, with chronic obstructive pulmonary diseases and asthma the most common (28 percent). Seven of 28 patients (25 percent) with roentgenographically detected lung lesions had carcinoma of the lung. Roentgenographic evidence of a lung lesion and C neoformans grown from the respiratory tract warrant a further search for carcinoma of the lung.

Entities:  

Mesh:

Year:  1977        PMID: 326497     DOI: 10.1378/chest.72.1.13

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.

Authors:  Ashok K Chaturvedi; Susan T Weintraub; Jose L Lopez-Ribot; Floyd L Wormley
Journal:  Proteomics       Date:  2013-12       Impact factor: 3.984

Review 2.  Immunologic tests in the diagnosis of pulmonary infection.

Authors:  E Goldstein; J Koo
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

3.  Therapy of Cryptococcal Meningitis in non-HIV-infected Patients.

Authors:  Peter G. Pappas
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.725

4.  STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.

Authors:  Chrissy M Leopold Wager; Camaron R Hole; Karen L Wozniak; Michal A Olszewski; Mathias Mueller; Floyd L Wormley
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

5.  Pulmonary cryptococcoma presenting as endobronchial mass mimicking malignancy in immunocompetent host.

Authors:  Hemant R Gupta; Ayaz M Ahmed; Balaram R Yadav; Samkit Mutha
Journal:  Lung India       Date:  2015 Sep-Oct

6.  Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.

Authors:  Karen L Wozniak; Mattie L Young; Floyd L Wormley
Journal:  Clin Vaccine Immunol       Date:  2011-03-30

7.  Fatal cryptococcosis in a patient with chronic renal failure: a case report.

Authors:  S K Lim; G P Verly; D F Jacob
Journal:  J Natl Med Assoc       Date:  1980-04       Impact factor: 1.798

8.  A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.

Authors:  Mattie Young; Sandra Macias; Derek Thomas; Floyd L Wormley
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

9.  Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice.

Authors:  T S Lim; J W Murphy; L K Cauley
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Direct determination of cryptococcal antigen in transthoracic needle aspirate for diagnosis of pulmonary cryptococcosis.

Authors:  Y S Liaw; P C Yang; C J Yu; D B Chang; H J Wang; L N Lee; S H Kuo; K T Luh
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.